REVIVE Study Apps

REVIVE GastroScreen
GastroScreen logo

REVIVE GastroScreen

REVIVE GastroScreen Eligibility Assessment
1 · Pepsinogens2 · Fasting G-17 3 · H. pylori IgGResult
Participant & Visit Information
Format: SITE-PARTICIPANT  (e.g. 1001-001)

Confirm that the participant has not taken any proton pump inhibitor, H2 receptor antagonist, or potassium-competitive acid blocker for at least 14 days prior to this visit.

1
Step 1 — Pepsinogen Panel
PGI
µg/L
PGII
µg/L
PGI:PGII Ratio AUTO
ratio
2
Step 2 — Fasting G-17 (G17b)
Fasting G-17 (G17b)*
pmol/L
Record the fasting G-17b value. Normal range: 1–7 pmol/L. Proceed to H. pylori assessment.
⚠ Required fields incomplete Complete all required fields (*) to generate an eligibility determination.
Awaiting Data Entry
Enter analyte values above to generate an eligibility determination.
IMPORTANT: This tool supports — but does not replace — clinical judgement. The PI retains final authority over all eligibility determinations. REVIVE GastroScreen biomarker criteria are the primary eligibility basis. All entries subject to audit. Verify against source laboratory documentation. For investigational use only — REVIVE Study · REVIVE GastroScreen
REVIVE Study Screening Predictor
REVIVE logo
REVIVE Study Screening Predictor
Cross-Lagged Trajectory Model · 7-Layer Decision Algorithm
eGFR < 60 mL/min
Bicarb 12–21 mEq/L
Not on chronic dialysis
1
Patient Demographics
2
Medications & Flags
Diabetes mellitus
Blunts ammoniagenesis → longer lag
Current alkali therapy
NaHCO₃ or Na-citrate supplement
ACEi / ARB (RAASi)
Minor eGFR-stabilizing effect
Currently on chronic dialysis
Hard exclusion (HD or PD)
Prior kidney transplant
Eligible — note for clinical review
Hospitalization in past 8 weeks
May distort bicarb trajectory
3
Serial Lab Values
DateeGFRBicarb
No readings yet
ℹ  Minimum 2 sets of labs required to generate a trajectory. More readings improve prediction accuracy — at least 3 labs spanning ≥ 2 months is preferred.
4
Screening Parameters
🔬
Ready to Predict
Enter patient demographics, medications, and serial lab values on the left,
then click Run Eligibility Prediction to see the traffic light output.

Click Load Example to see the index case (bicarb 22–23 at screening).
⚠️
Research Use & Pre-Screening Tool Only — Not for Clinical or Diagnostic Use
This tool is intended solely for use by qualified research personnel to assist in assessing potential screening eligibility for the REVIVE Study, a clinical trial sponsored by Renibus Therapeutics. It is designed as a pre-screening aid only and does not constitute medical advice, clinical diagnosis, or a basis for clinical decision-making of any kind. All outputs are predictive estimates based on a statistical model that has not been prospectively validated and may not reflect individual patient circumstances. Final eligibility determinations must be made by a qualified investigator in accordance with the official REVIVE Study protocol, applicable regulatory requirements, and independent clinical judgment. This tool does not establish a patient–provider relationship and must not be used as a substitute for professional medical evaluation. Renibus Therapeutics and its affiliates make no warranties, express or implied, regarding the accuracy, completeness, or fitness for any particular purpose of this tool or its outputs.
REVIVE Study Screening Predictor
REVIVE logo
REVIVE Study Screening Predictor
Cross-Lagged Trajectory Model · 7-Layer Decision Algorithm
eGFR < 60 mL/min
Bicarb 12–21 mEq/L
Not on chronic dialysis
1
Patient Demographics
2
Medications & Flags
Diabetes mellitus
Blunts ammoniagenesis → longer lag
Current alkali therapy
NaHCO₃ or Na-citrate supplement
ACEi / ARB (RAASi)
Minor eGFR-stabilizing effect
Currently on chronic dialysis
Hard exclusion (HD or PD)
Prior kidney transplant
Eligible — note for clinical review
Hospitalization in past 8 weeks
May distort bicarb trajectory
3
Serial Lab Values
DateeGFRBicarb
No readings yet
ℹ  Minimum 2 sets of labs required to generate a trajectory. More readings improve prediction accuracy — at least 3 labs spanning ≥ 2 months is preferred.
4
Screening Parameters
🔬
Ready to Predict
Enter patient demographics, medications, and serial lab values on the left,
then click Run Eligibility Prediction to see the traffic light output.

Click Load Example to see the index case (bicarb 22–23 at screening).
⚠️
Research Use & Pre-Screening Tool Only — Not for Clinical or Diagnostic Use
This tool is intended solely for use by qualified research personnel to assist in assessing potential screening eligibility for the REVIVE Study, a clinical trial sponsored by Renibus Therapeutics. It is designed as a pre-screening aid only and does not constitute medical advice, clinical diagnosis, or a basis for clinical decision-making of any kind. All outputs are predictive estimates based on a statistical model that has not been prospectively validated and may not reflect individual patient circumstances. Final eligibility determinations must be made by a qualified investigator in accordance with the official REVIVE Study protocol, applicable regulatory requirements, and independent clinical judgment. This tool does not establish a patient–provider relationship and must not be used as a substitute for professional medical evaluation. Renibus Therapeutics and its affiliates make no warranties, express or implied, regarding the accuracy, completeness, or fitness for any particular purpose of this tool or its outputs.

Hello, World!